Still Threshold 12 welcomes corrections, questions, or feedback about our published content. We aim for clarity and accuracy; if you see an error or have information that should be considered, please let us know through the channels noted below.
At present this site has no public email or contact form available. We invite readers to check the About page for the project's published channels and editorial procedures; the About page explains how we handle corrections and sourcing concerns and how to contact the team when direct contact is available.
Read about our editorial approach on the About page, which describes how we review and update material.
If you are navigating here from another page, a concise route back to the site's front is available via the main site index; use our site header or this inline link to return to Still Threshold 12's main entry to explore other pages and resources.
We welcome factual corrections and documentation. When contact channels are published, they are described on our About page's editorial procedures. Until then, please check back periodically for updated contact details.
The site currently does not publish a direct email or public contact form. This approach helps us prioritize careful review before opening live correspondence channels; consult the About page for future updates and any published outreach methods.
Still Threshold 12 is an independent resource on ibogaine risks and treatment-related deaths. Our mission and values—Safety first · Plain language · Evidence limits · Transparency · Human dignity—are described on the site and on the About page.